Integrum

Sep 27, 2023

Integrum AB Wed, Sep 27, 2023 10:13 CET Mölndal, Sweden, September 27, 2023 – Integrum (publ) (Nasdaq First North Growth Market: INTEG B) announces today that the company is attending an international meeting and workshop event gathering experts in the field of osseointegration and bionic limb reconstruction, at the prestigious Rizzoli Orthopaedic Institute at the University of Bologna, Italy, on October 18–19th. Integrum AB is the main sponsor for the International Workshop on Osseointegration and Bionic Limb Reconstruction at the prestigious Rizzoli Orthopaedic Institute in Bologna, October 18th-19th 2023. The meeting will gather a select group of global pioneering experts, working in medicine and bioengineering to further the field of limb reconstruction. The overarching aim of the event is to share new insights and knowledge to develop clinical solutions that improve the function and quality of life for individuals living with an amputated limb today, and tomorrow. “I look forward to taking part in the latest discussions concerning the development of limb reconstruction techniques based on osseointegration and bionics. To maintain our position as one of the leading companies in the field, it is important to continuously communicate our insights, gained from applying our solutions in patients, and fortify our connections with the forefront of academic and clinical researchers and experts” comments Rickard Brånemark, CEO of Integrum. The Rizzoli Orthopaedics Institute is the main institute of orthopaedics and traumatology in Italy. With about 150,000 patients examined each year and 18,000 orthopaedic operations, it also has strong scientific research which is carried out in their 9 laboratories. The Rizzoli Orthopaedics Institute is one of the most prestigious hospitals in the world and was recently ranked the number 5 orthopaedic hospital in the world by Newsweek . For more information please contact: Jörgen Svanström, CFO. Phone: +46 (0) 70 734 96 60, E-mail: jorgen.svanstrom@integrum.se Certified Adviser Erik Penser Bank is Certified Adviser. Integrum AB is a publicly traded company (INTEG B: Nasdaq First North exchange) based outside of Gothenburg, Sweden, with a US subsidiary in San Francisco, CA. Since 1990, osseointegration, the science behind the OPRA™ Implant System, has been helping individuals with amputations enjoy a dramatically improved quality of life. Thorough surgical experience gained over more than three decades, from more than 500 surgeries, in 14 countries, has led to the development of Integrum’s system for bone-anchored prostheses – a vastly superior alternative to the traditionally used socket prosthesis.